The survival gap between young and older patients after surgical resection for colorectal cancer remains largely based on early mortality: A EURECCA comparison of four European countries.


Journal

Journal of geriatric oncology
ISSN: 1879-4076
Titre abrégé: J Geriatr Oncol
Pays: Netherlands
ID NLM: 101534770

Informations de publication

Date de publication:
07 2022
Historique:
received: 21 09 2021
revised: 21 03 2022
accepted: 15 04 2022
pubmed: 9 5 2022
medline: 19 7 2022
entrez: 8 5 2022
Statut: ppublish

Résumé

A decade ago, it was demonstrated that the difference in survival between older patients and younger patients with colorectal cancer (CRC) was mainly due to mortality in the first postoperative year. Over the last few years, improvements - especially in perioperative care - have increased survival. The current research investigates whether a survival gap between younger and older patients with CRC still exists on a national level in four European countries. Population-based data from Belgium, the Netherlands, Norway, and Sweden were collected from patients that underwent surgical resection for primary stage I-III CRC between 2007 and 2016. Relative survival and conditional relative survival (CS), with the condition of surviving the first postoperative year, were calculated for colon and rectal cancer separately, stratified for country and age category (<65, 65-75, ≥75 years). In addition, relative excess risk of death (RER) was estimated, and one-year excess mortality was calculated. Data of 206,024 patients were analyzed. In general, compared to patients <65 years, patients ≥75 years had a worse survival during the first year after surgery, which was most pronounced in Belgium (RER colon cancer 2.5 [95% confidence interval (CI) 2.3-2.8] and RER rectal cancer 2.6 [95% CI 2.3-2.9]). After surviving the first year, CS was mostly not statistically different between patients <65 years and patients ≥75 years with stage I-II, with the exception of stage II colon cancer in Belgium. However, CS remained worse in the largest part of the patients ≥75 years with stage III colon or rectal cancer (except for rectal cancer in Norway). Although differences exist between the countries, the survival gap between young and older patients is based mainly on early mortality and remains only for stage III disease after surviving the first year.

Sections du résumé

BACKGROUND
A decade ago, it was demonstrated that the difference in survival between older patients and younger patients with colorectal cancer (CRC) was mainly due to mortality in the first postoperative year. Over the last few years, improvements - especially in perioperative care - have increased survival. The current research investigates whether a survival gap between younger and older patients with CRC still exists on a national level in four European countries.
METHODS
Population-based data from Belgium, the Netherlands, Norway, and Sweden were collected from patients that underwent surgical resection for primary stage I-III CRC between 2007 and 2016. Relative survival and conditional relative survival (CS), with the condition of surviving the first postoperative year, were calculated for colon and rectal cancer separately, stratified for country and age category (<65, 65-75, ≥75 years). In addition, relative excess risk of death (RER) was estimated, and one-year excess mortality was calculated.
RESULTS
Data of 206,024 patients were analyzed. In general, compared to patients <65 years, patients ≥75 years had a worse survival during the first year after surgery, which was most pronounced in Belgium (RER colon cancer 2.5 [95% confidence interval (CI) 2.3-2.8] and RER rectal cancer 2.6 [95% CI 2.3-2.9]). After surviving the first year, CS was mostly not statistically different between patients <65 years and patients ≥75 years with stage I-II, with the exception of stage II colon cancer in Belgium. However, CS remained worse in the largest part of the patients ≥75 years with stage III colon or rectal cancer (except for rectal cancer in Norway).
CONCLUSIONS
Although differences exist between the countries, the survival gap between young and older patients is based mainly on early mortality and remains only for stage III disease after surviving the first year.

Identifiants

pubmed: 35527207
pii: S1879-4068(22)00103-5
doi: 10.1016/j.jgo.2022.04.011
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

803-812

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Renu R Bahadoer (RR)

Leiden University Medical Center, Department of Surgery, Albinusdreef 2, Postbus 9600, 2300 RC Leiden, the Netherlands. Electronic address: R.R.Bahadoer@lumc.nl.

Esther Bastiaannet (E)

Leiden University Medical Center, Department of Surgery, Albinusdreef 2, Postbus 9600, 2300 RC Leiden, the Netherlands; Leiden University Medical Center, Department of Medical Oncology, Albinusdreef 2, Postbus 9600, 2300 RC Leiden, the Netherlands. Electronic address: E.Bastiaannet@lumc.nl.

Koen C M J Peeters (KCMJ)

Leiden University Medical Center, Department of Surgery, Albinusdreef 2, Postbus 9600, 2300 RC Leiden, the Netherlands. Electronic address: K.C.M.J.Peeters@lumc.nl.

Elizabeth van Eycken (E)

Belgian Cancer Registry, Koningsstraat 215 bus 7, 1210 Brussels, Belgium. Electronic address: elizabeth.vaneycken@kankerregister.org.

Julie Verbeeck (J)

Belgian Cancer Registry, Koningsstraat 215 bus 7, 1210 Brussels, Belgium. Electronic address: Julie.Verbeeck@registreducancer.org.

Marianne G Guren (MG)

Oslo University Hospital, Department of Oncology, PO 4953 Nydalen, 0424 Oslo, Norway. Electronic address: Marianne.Gronlie.Guren@ous-hf.no.

Hartwig Kørner (H)

Stavanger University Hospital, Stavanger, Department of Gastrointestinal Surgery, Postboks 8100, 4068 Stavanger, Norway; University of Bergen, Department of Clinical Medicine, Jonas Lies veg 87, N-5021 Bergen, Norway. Electronic address: hartwig.korner@uib.no.

Anna Martling (A)

Karolinska Institutet, Department of Molecular Medicine and Surgery, Solnavägen 1, 171 77 Stockholm, Sweden. Electronic address: anna.martling@ki.se.

Robert Johansson (R)

Umeå University, The Biobank Research Unit, 901 87 Umeå, Sweden. Electronic address: robert.johansson01@umu.se.

Cornelis J H van de Velde (CJH)

Leiden University Medical Center, Department of Surgery, Albinusdreef 2, Postbus 9600, 2300 RC Leiden, the Netherlands. Electronic address: C.J.H.van_de_Velde@lumc.nl.

Jan Willem T Dekker (JWT)

Reinier de Graaf Hospital, Department of Surgery, Reinier de Graafweg 5, Postbus 5011, 2600 GA Delft, the Netherlands. Electronic address: J.W.T.Dekker@rdgg.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH